AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

IMMURON LTD

0.070

+0.0011.45%

Volume:121.39K

Turnover:8.50K

Market Cap:16.38M

PE:-2.17

High:0.070

Open:0.070

Low:0.070

Close:0.069

Loading ...

Overview Company News Filings

Immuron Ltd-Proposed Issue of Securities - Imc

THOMSON REUTERS

Immuron - Fy25 Global Sales Exceed Projection, Up 49% On Prior Year

Immuron Limited Reports FY25 Sales Up 49% to AUD$7.3 Million, Driven by Strong Travelan Performance

Immuron - FY25 Global Sales Exceed Projection, up 49% on Prior Year

THOMSON REUTERS

Immuron Ltd - June Quarter Sales AUD$2.0 Mln, up 55%

THOMSON REUTERS

Immuron Posts Higher June Quarter Sales

MT Newswires Live

BRIEF-Immuron Posts Global Annual Sales AUD$7.3 Million

BUZZ-Australia's Immuron jumps on upbeat annual sales

Notice under section 708A-IMC.AX

Immuron Ltd -in FY26 We Will Invest to Grow in North America

THOMSON REUTERS

Immuron Ltd - Global Annual Sales AUD$7.3 Mln

THOMSON REUTERS

Immuron Ltd-Proposed Issue of Securities - Imc

THOMSON REUTERS

Proposed issue of securities - IMC-IMC.AX

Change in substantial holding-IMC.AX

Immuron Limited Announces New Share Issue with 116,680 Ordinary Fully Paid Securities Quoted

Immuron Ltd-Proposed Issue of Securities - Imc

THOMSON REUTERS

Immuron Sees Higher Fiscal 2025 Sales

MT Newswires Live

Immuron Limited Projects Record-Breaking Sales, On Track to Surpass A$7 Million This Financial Year

Immuron Ltd - on Track to Exceed a$7 Mln in Sales This Year

THOMSON REUTERS

Immuron Letter to Shareholders: Projects Update

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IMC.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMC.AU\",,,,,undefined,":{"symbol":"IMC.AU","market":"AU","secType":"STK","nameCN":"IMMURON LTD","latestPrice":0.07,"timestamp":1753251120000,"preClose":0.069,"halted":0,"volume":121390,"delay":0,"nameEN":"IMMURON LTD","floatShares":231113346,"shares":233959013,"eps":-0.032226,"marketStatus":"Closed","change":0.001,"latestTime":"07-23 16:12:00 AEST","open":0.07,"high":0.07,"low":0.07,"amount":8497,"amplitude":0,"askPrice":0.077,"askSize":64998,"bidPrice":0.069,"bidSize":500000,"shortable":3,"etf":0,"ttmEps":-0.032226,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753315200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.069,"openAndCloseTimeList":[[1753228800000,1753250400000]],"volumeRatio":0.141232,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMC.AU\",,,,,undefined,":{"symbol":"IMC.AU","floatShares":231113346,"roa":"-22.36%","roe":"-52.77%","lyrEps":-0.030443,"volumeRatio":0.141232,"shares":233959013,"dividePrice":0,"high":0.07,"amplitude":0,"preClose":0.069,"low":0.07,"week52Low":0.054,"pbRate":"1.58","psRate":"2.50","week52High":0.11,"institutionHeld":0,"latestPrice":0.07,"committee":0.769918,"eps":-0.032226,"divideRate":0,"volume":121390,"delay":0,"ttmEps":-0.032226,"open":0.07,"prevYearClose":0.079,"prevWeekClose":0.076,"prevMonthClose":0.061,"prevQuarterClose":0.061,"fiveDayClose":0.065,"twentyDayClose":0.062,"sixtyDayClose":0.063},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMC.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552532514","title":"Immuron Ltd-Proposed Issue of Securities - Imc","url":"https://stock-news.laohu8.com/highlight/detail?id=2552532514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552532514?lang=en_us&edition=fundamental","pubTime":"2025-07-18 10:08","pubTimestamp":1752804503,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nTUEBD8GTQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMC.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2552489536","title":"Immuron - Fy25 Global Sales Exceed Projection, Up 49% On Prior Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489536","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489536?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:08","pubTimestamp":1752754121,"startTime":"0","endTime":"0","summary":"Immuron Ltd ::*IMMURON - FY25 GLOBAL SALES EXCEED PROJECTION, UP 49% ON PRIOR YEAR*IMMURON LTD - JUNE QUARTER SALES AUD$2.0 MILLION, UP 55%  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 17-JUL-202510:00:00.127 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nRSD84c0mD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU"],"gpt_icon":0},{"id":"2552000731","title":"Immuron Limited Reports FY25 Sales Up 49% to AUD$7.3 Million, Driven by Strong Travelan Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2552000731","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552000731?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:00","pubTimestamp":1752746413,"startTime":"0","endTime":"0","summary":"Immuron Limited , an Australian-based biopharmaceutical company, announced a significant increase in sales for the fiscal year 2025, with global sales reaching AUD$7.3 million, marking a 49% increase compared to the previous year. The company's product, Travelan, an over-the-counter immune supplement, has driven this growth. In Australia, annual sales rose by 40% to AUD$5.2 million, supported by increased consumer engagement and a focused pharmacy visibility program. Meanwhile, North American sales reached AUD$2 million, a 76% increase from the prior year, bolstered by improved communication strategies and enhanced distribution in Canada. For the June 2025 quarter, global sales were AUD$2.0 million, a 55% increase from the same period last year. Australian sales for the quarter were AUD$1.5 million, up 58%, and North American sales were AUD$0.5 million, with a 49% increase. Looking forward, Immuron plans to continue investing in the North American market while maintaining the momentum ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL7w0R01:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","NDAQ"],"gpt_icon":0},{"id":"2552100732","title":"Immuron - FY25 Global Sales Exceed Projection, up 49% on Prior Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2552100732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552100732?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:00","pubTimestamp":1752746401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nTUA7FTJQS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","IMC.AU"],"gpt_icon":0},{"id":"2552100063","title":"Immuron Ltd - June Quarter Sales AUD$2.0 Mln, up 55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552100063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552100063?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:00","pubTimestamp":1752746401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nTUA7FTJQS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMC.AU","BK7067"],"gpt_icon":0},{"id":"2552106701","title":"Immuron Posts Higher June Quarter Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2552106701","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552106701?lang=en_us&edition=fundamental","pubTime":"2025-07-17 15:26","pubTimestamp":1752737178,"startTime":"0","endTime":"0","summary":"Immuron  reported global sales of AU$2 million for the June quarter, up 55% from a year ago, according to a Thursday Australian bourse filing.Global sales for the fiscal year were up 49% from a year ago at AU$7.3 million, helped by AU$5.2 million sales from Australia and AU$2 million sales from North America.The company's shares rose 14% on market close.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMC.AU"],"gpt_icon":0},{"id":"2552171947","title":"BRIEF-Immuron Posts Global Annual Sales AUD$7.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2552171947","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552171947?lang=en_us&edition=fundamental","pubTime":"2025-07-17 09:25","pubTimestamp":1752715533,"startTime":"0","endTime":"0","summary":"BRIEF-Immuron Posts Global Annual Sales AUD$7.3 MillionJuly 17 (Reuters) - Immuron Ltd IMC.AX:GLOBAL ANNUAL SALES AUD$7.3 MILLIONIN FY26 WE WILL INVEST TO GROW IN NORTH AMERICAFurther company coverage: IMC.AX ((Reuters.Briefs@thomsonreuters.com))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TD18X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU"],"gpt_icon":0},{"id":"2552717928","title":"BUZZ-Australia's Immuron jumps on upbeat annual sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2552717928","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552717928?lang=en_us&edition=fundamental","pubTime":"2025-07-17 09:02","pubTimestamp":1752714145,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Immuron jumps on upbeat annual sales** Shares of Immuron IMC.AX rise 26.2% to A$0.082, their highest since February 28** Biopharmaceutical co reports FY25 global annual sales of A$7.3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nL4N3TE01T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU"],"gpt_icon":0},{"id":"2552764341","title":"Notice under section 708A-IMC.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2552764341","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552764341?lang=en_us&edition=fundamental","pubTime":"2025-07-17 07:56","pubTimestamp":1752710186,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250716:nASX9VmC6M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nASX3LQlq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","IMC.AU"],"gpt_icon":0},{"id":"2552917569","title":"Immuron Ltd -in FY26 We Will Invest to Grow in North America","url":"https://stock-news.laohu8.com/highlight/detail?id=2552917569","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552917569?lang=en_us&edition=fundamental","pubTime":"2025-07-17 06:45","pubTimestamp":1752705920,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nFWN3TD18X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMC.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2552175695","title":"Immuron Ltd -  Global Annual Sales AUD$7.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2552175695","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552175695?lang=en_us&edition=fundamental","pubTime":"2025-07-17 06:45","pubTimestamp":1752705920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nFWN3TD18X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","IMC.AU"],"gpt_icon":0},{"id":"2551553119","title":"Immuron Ltd-Proposed Issue of Securities - Imc","url":"https://stock-news.laohu8.com/highlight/detail?id=2551553119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551553119?lang=en_us&edition=fundamental","pubTime":"2025-07-16 10:59","pubTimestamp":1752634788,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nTUE1VY1JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","IMC.AU","BK7508"],"gpt_icon":0},{"id":"2551192321","title":"Proposed issue of securities - IMC-IMC.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2551192321","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551192321?lang=en_us&edition=fundamental","pubTime":"2025-07-16 10:59","pubTimestamp":1752634788,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250716:nASX7BSZg","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nASX4lFTdP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","IMC.AU"],"gpt_icon":0},{"id":"2548045252","title":"Change in substantial holding-IMC.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2548045252","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548045252?lang=en_us&edition=fundamental","pubTime":"2025-07-01 06:27","pubTimestamp":1751322476,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250630:nASX1yxWFp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nASX2r3Lgc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2540063294","title":"Immuron Limited Announces New Share Issue with 116,680 Ordinary Fully Paid Securities Quoted","url":"https://stock-news.laohu8.com/highlight/detail?id=2540063294","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540063294?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:00","pubTimestamp":1749038456,"startTime":"0","endTime":"0","summary":"Immuron Limited has announced a new issue of ordinary fully paid shares, with 116,680 securities set to be quoted. This issuance is part of a previously announced transaction, as outlined in an earlier Appendix 3B submission. The new shares are scheduled for issue on June 3, 2025, under the ASX security code IMC. This move by the company aligns with its ongoing strategy to enhance its capital structure and fund its business operations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuron Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2025, and is solely responsible for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDLc8MNFC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","IMC.AU"],"gpt_icon":0},{"id":"2540742003","title":"Immuron Ltd-Proposed Issue of Securities - Imc","url":"https://stock-news.laohu8.com/highlight/detail?id=2540742003","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540742003?lang=en_us&edition=fundamental","pubTime":"2025-06-03 14:39","pubTimestamp":1748932770,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nTUE1VLS0V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMC.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2540755219","title":"Immuron Sees Higher Fiscal 2025 Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2540755219","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540755219?lang=en_us&edition=fundamental","pubTime":"2025-06-02 09:08","pubTimestamp":1748826496,"startTime":"0","endTime":"0","summary":"Immuron  said fiscal 2025 sales are \"on track\" to exceed AU$7 million, up from AU$4.9 million a year earlier, according to a May 30 filing with the Australian bourse.All of the US armed services participants in the field study for Travelan, the company's therapy candidate for traveler's diarrhea, have been deployed, the filing said.The biopharmaceutical firm expects the final visit of the last patient in July, with results slated for release in October, the filing added.The company also expects an investigational new drug submission for IMM-529, a drug candidate for colon infection, to the US Food and Drug Administration in August.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMC.AU"],"gpt_icon":0},{"id":"2539223305","title":"Immuron Limited Projects Record-Breaking Sales, On Track to Surpass A$7 Million This Financial Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2539223305","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539223305?lang=en_us&edition=fundamental","pubTime":"2025-05-30 18:00","pubTimestamp":1748599216,"startTime":"0","endTime":"0","summary":"Immuron Limited, an Australian-based biopharmaceutical company, has announced a positive financial outlook for the current year, projecting sales to exceed A$7 million. This marks a significant increase from the A$4.9 million achieved in the previous year. The company attributes this growth to record sales up to the end of March, continuing momentum through the Easter and ANZAC holiday periods, and the spring and summer break in North America. Immuron's Chief Executive Officer, Steven Lydeamore, highlighted that the company is on track to surpass these sales figures, underscoring a momentous rise in revenue. Additionally, Immuron's clinical product, IMM-124E , is anticipated to generate US$102 million in yearly revenue in the United States, based on Lumanity's opportunity assessment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for info","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL1y3bbG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","NDAQ"],"gpt_icon":0},{"id":"2539995223","title":"Immuron Ltd - on Track to Exceed a$7 Mln in Sales This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2539995223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539995223?lang=en_us&edition=fundamental","pubTime":"2025-05-30 18:00","pubTimestamp":1748599200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nTUADPKPW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMC.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2539228020","title":"Immuron Letter to Shareholders: Projects Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2539228020","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539228020?lang=en_us&edition=fundamental","pubTime":"2025-05-30 18:00","pubTimestamp":1748599200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nTUADPKPW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMC.AU","BK7067","BK7508"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMC.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-02-28","symbol":"IMC.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1677502800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMC.AU\",market:\"AU\",,,undefined,":[]}}